Methylprednisolone in adults hospitalized with COVID-19 pneumonia: An open-label randomized trial (GLUCOCOVID)

PURPOSE: To determine whether a 6-day course of methylprednisolone (MP) improves outcome in patients with severe SARS-CoV‑2 (Corona Virus Disease 2019 [COVID-19]). METHODS: The study was a multicentric open-label trial of COVID-19 patients who were aged ≥ 18 years, receiving oxygen without mechanica...

Descripción completa

Detalles Bibliográficos
Autores principales: Corral-Gudino, Luis, Bahamonde, Alberto, Arnaiz-Revillas, Francisco, Gómez-Barquero, Julia, Abadía-Otero, Jesica, García-Ibarbia, Carmen, Mora, Víctor, Cerezo-Hernández, Ana, Hernández, José L., López-Muñíz, Graciela, Hernández-Blanco, Fernando, Cifrián, Jose M., Olmos, Jose M., Carrascosa, Miguel, Nieto, Luis, Fariñas, María Carmen, Riancho, José A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854876/
https://www.ncbi.nlm.nih.gov/pubmed/33534047
http://dx.doi.org/10.1007/s00508-020-01805-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854876/
https://www.ncbi.nlm.nih.gov/pubmed/33534047
http://dx.doi.org/10.1007/s00508-020-01805-8

Ejemplares similares